Advaxis Enters into Collaboration with the University of British Columbia

Source: Market Watch Posted By: Ronny F...4919 days ago

Advaxis, Inc., /quotes/comstock/11k!adxs (ADXS 0.14, 0.00, 0.00%) , the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has entered into a structured collaboration with the laboratory of Dr. Tobias Kollmann at the University of British Columbia (UBC) to develop live attenuated Listeria vaccines for the treatment of infectious disease and for new dosage forms of Listeria vaccines.

The same immune-stimulating properties that are under development at Advaxis to develop....

Read full story >>

• (0 vote)   

•  
• Comments(0)|
• Report It|
• Blog It